BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial

BACKGROUND: Trials done in infants with low birthweight in west Africa suggest that BCG vaccination reduces all-cause mortality in the neonatal period, probably because of heterologous protection against non-tuberculous infections. This study investigated whether BCG alters all-cause infectious dise...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lancet Infect Dis
Hlavní autoři: Prentice, Sarah, Nassanga, Beatrice, Webb, Emily L, Akello, Florence, Kiwudhu, Fred, Akurut, Hellen, Elliott, Alison M, Arts, Rob J W, Netea, Mihai G, Dockrell, Hazel M, Cose, Stephen
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier Science ;, The Lancet Pub. Group 2021
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8222005/
https://ncbi.nlm.nih.gov/pubmed/33609457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(20)30653-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky